SINTX Technologies Inc
NASDAQ:SINT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.73
5.53
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
SINTX Technologies Inc
Cash from Operating Activities
SINTX Technologies Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
SINTX Technologies Inc
NASDAQ:SINT
|
Cash from Operating Activities
-$7.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$4.6B
|
CAGR 3-Years
57%
|
CAGR 5-Years
25%
|
CAGR 10-Years
21%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$4.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$9.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Cash from Operating Activities
$1.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
SINTX Technologies Inc
Glance View
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 36 full-time employees. The company went IPO on 2014-02-11. The firm is focused on manufacturing, research and development of silicon nitride ceramics for external partners. The firm's medical-grade silicon nitride products includes FleX SN-MC2, FleX SN-CSC, FleX SN-PEEK and FleX SN-AP, which are biocompatible, bioactive, antipathogenic and has a bone affinity. The firm's antipathogenic product, FleX SN-AP, which is a silicon nitride antipathogenic powder used in manufacturing of products such as face masks and personal protective equipment. The firm's non-medical applications are used in manufacturing of ceramic armors for the aerospace and defense industries. Its industrial silicon nitride has a combination of mechanical, thermal and electrical properties of any technical ceramic material.
See Also
What is SINTX Technologies Inc's Cash from Operating Activities?
Cash from Operating Activities
-7.4m
USD
Based on the financial report for Sep 30, 2025, SINTX Technologies Inc's Cash from Operating Activities amounts to -7.4m USD.
What is SINTX Technologies Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
3%
Over the last year, the Cash from Operating Activities growth was 31%. The average annual Cash from Operating Activities growth rates for SINTX Technologies Inc have been 11% over the past three years , 3% over the past five years , and 3% over the past ten years .